Despite the recovery, the company is not using stronger short-term earnings as a reason to resume aggressive commodity expansion.
Instead, its strategy for the remainder of the decade focuses on feedstock flexibility, cost reduction, Specialty Chemicals and Green & Bio businesses.
Feedstock strategy remains central to protecting the competitiveness of GC’s petrochemical base.
The company plans to begin importing ethane from the United States in 2029, using lower-cost feedstock to improve long-term production economics.
GC has said its existing facilities are already capable of handling ethane without requiring major infrastructure modifications.
The approach shows that GC is not abandoning commodity petrochemicals.
Rather, it is attempting to make the existing core more competitive while directing incremental growth toward businesses with stronger margins.
Specialty Chemicals expansion will rely heavily on allnex, GC’s global coatings resins and additives platform.
The company said allnex will serve as a major engine for expanding its specialty portfolio, with new capacity being developed across Asia.
At Map Ta Phut in Thailand, allnex is adding Sagging Control Agent production, which GC says will become the company’s first SCA manufacturing base outside Europe.
Allnex is also expanding its footprint in Jiaxing, China, and Mahad, India, giving GC broader exposure to growing coatings, automotive, industrial and performance-materials markets across Asia.
These businesses operate under very different economics from conventional olefins and polyolefins.
Commodity petrochemicals depend heavily on scale, feedstock costs and market cycles. Specialty resins and additives rely more on technical performance, customer qualification, formulation expertise and application support.
Increasing the specialty share could therefore help GC build a portfolio with less earnings volatility and stronger customer relationships.
Green & Bio represents the other major growth pillar.
Through NatureWorks, GGC, Emery Oleochemicals and ENVICCO, the group has established positions in bio-based chemicals, PLA bioplastics, oleochemicals and food-grade recycled plastics.
GC said NatureWorks has recently opened its new integrated PLA plant at the Nakhon Sawan Bio Complex in Thailand, linking local agricultural feedstocks with biotechnology to produce higher-value bio-based materials.
The company also plans to transform Map Ta Phut from a conventional petrochemical production center into a broader Asia-Pacific growth hub spanning commodity chemicals, Specialty and Green & Bio businesses.
The “MTP Transformation” strategy will use the site’s existing refining, petrochemical, utilities and logistics infrastructure as a platform for higher-value materials and technology-driven businesses.
GC is simultaneously studying a potential olefins and polyolefins joint venture with SCG Chemicals.
The feasibility study is expected to reach a conclusion by the end of the third quarter of 2026. If the combination proceeds, GC says the resulting platform could become one of Southeast Asia’s leading olefins and polyolefins producers, with production scale ranking among the global top tier.
The study reinforces the direction of GC’s strategy.
Rather than independently adding more conventional petrochemical capacity, the company is considering consolidation to improve scale efficiency while directing more capital toward differentiated products.
The shift is increasingly representative of the Asian petrochemical industry.
Years of capacity additions in China, the Middle East and other parts of Asia have created structural supply pressure across several commodity product chains.
Large Asian producers are therefore beginning to adopt some of the portfolio strategies already visible among European and U.S. chemical groups: retain competitive integrated assets while increasing exposure to specialties, sustainable materials and technology-driven products.
GC’s target of increasing higher-value businesses to 30% of its portfolio is ultimately a direct response to the lower-return environment facing global petrochemicals.
The transformation will take time.
Specialty Chemicals must continue expanding customers and technical capabilities, while Green & Bio businesses still need to demonstrate scalable profitability. Commodity petrochemicals will continue to generate the majority of GC’s revenue and cash flow for years.
Whether the group reaches its 70:30 portfolio target by 2030 will therefore depend on the execution of the allnex expansion, U.S. ethane project, Green & Bio investments and potential SCGC partnership.
Overall, GC is not preparing to leave traditional petrochemicals.
It is attempting a more complex restructuring.
PTT Global Chemical wants a lower-cost commodity petrochemical core to support cash generation while Specialty and Green & Bio become the engines of its next growth cycle.
